A Multicenter Phase 2 Study of the Glutaminase Inhibitor CB-839 in Combination with Paclitaxel in Patients with Advanced Triple Negative Breast Cancer (TNBC) Including Patients of African Ancestry and Non-African Ancestry

Type of Cancer
Breast Oncology

Sponsor
cALITHERA

Protocol Number
cx-839-007

To Learn More Call
(201)-510-0950